<?xml version="1.0" encoding="UTF-8"?>
<ref id="B155-ijms-21-09461">
 <label>155.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Dong</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Shang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>LncSubpathway: A Novel Approach for Identifying Dysfunctional Subpathways Associated with Risk LncRNAs by Integrating LncRNA and MRNA Expression Profiles and Pathway Topologies</article-title>
  <source>Oncotarget</source>
  <year>2017</year>
  <volume>8</volume>
  <fpage>15453</fpage>
  <lpage>15469</lpage>
  <pub-id pub-id-type="doi">10.18632/oncotarget.14973</pub-id>
  <pub-id pub-id-type="pmid">28152521</pub-id>
 </element-citation>
</ref>
